Home

myocarditis cases per year

Occurrence and Features of Childhood Myocarditis: A Nationwide Study in  Finland | Journal of the American Heart Association
Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association

The effects of gender and age on occurrence of clinically suspected  myocarditis in adulthood | Heart
The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood | Heart

NEJM on X: "Among 2.5 million patients who received the BNT162b2 mRNA  vaccine in a large Israeli health care system, the incidence of myocarditis  at 42 days was 2.13 cases per 100,000
NEJM on X: "Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000

Myocarditis mortality with and without COVID-19: insights from a national  registry | Clinical Research in Cardiology
Myocarditis mortality with and without COVID-19: insights from a national registry | Clinical Research in Cardiology

Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in  Australia: a Bayesian network analysis | medRxiv
Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis | medRxiv

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based  cohort study | The BMJ
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study | The BMJ

COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic  Uncertainty | Journal of the American College of Cardiology
COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic Uncertainty | Journal of the American College of Cardiology

Frontiers | Global, Regional, and National Burden of Myocarditis and  Cardiomyopathy, 1990–2017
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017

Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in  Pediatric Heart Transplant Recipients? | Circulation: Heart Failure
Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? | Circulation: Heart Failure

JCM | Free Full-Text | Epidemiological Impact of Myocarditis
JCM | Free Full-Text | Epidemiological Impact of Myocarditis

Abstract 11463: Epidemiological Trends and Outcomes of Acute Myocarditis in  the National Health Service of England | Circulation
Abstract 11463: Epidemiological Trends and Outcomes of Acute Myocarditis in the National Health Service of England | Circulation

Long-Term Outcome of Fulminant Myocarditis as Compared with Acute  (Nonfulminant) Myocarditis | NEJM
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis | NEJM

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19  Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR

Myocarditis mortality with and without COVID-19: insights from a national  registry | Clinical Research in Cardiology
Myocarditis mortality with and without COVID-19: insights from a national registry | Clinical Research in Cardiology

COVID-19 infection more likely than vaccines to cause rare cardiovascular  complications — Nuffield Department of Primary Care Health Sciences,  University of Oxford
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications — Nuffield Department of Primary Care Health Sciences, University of Oxford

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM

While rare, myocarditis after COVID-19 vaccination is more common in young  men
While rare, myocarditis after COVID-19 vaccination is more common in young men

Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA  Vaccines in Ontario: December 13, 2020 to November 21, 202
Myocarditis and Pericarditis Following Vaccination with COVID-19 mRNA Vaccines in Ontario: December 13, 2020 to November 21, 202

Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and  Utilization of Mechanical Circulatory Support Devices in Myocarditis  (Analysis of National Inpatient Sample Data, 2005–2014) - ScienceDirect
Trends in the Incidence of In-Hospital Mortality, Cardiogenic Shock, and Utilization of Mechanical Circulatory Support Devices in Myocarditis (Analysis of National Inpatient Sample Data, 2005–2014) - ScienceDirect

Occurrence and Features of Childhood Myocarditis: A Nationwide Study in  Finland | Journal of the American Heart Association
Occurrence and Features of Childhood Myocarditis: A Nationwide Study in Finland | Journal of the American Heart Association

Association Between COVID-19 and Myocarditis Using Hospital-Based  Administrative Data — United States, March 2020–January 2021 | MMWR
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR

Systematic analysis of drug-associated myocarditis reported in the World  Health Organization pharmacovigilance database | Nature Communications
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database | Nature Communications

JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of  Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year  Perspectives from the MYO-PL Nationwide Database
JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year Perspectives from the MYO-PL Nationwide Database